Talampanel Completed Phase 2 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00267592Safety and Efficacy of Talampanel in Glioblastoma Multiforme